Convergence Investment Partners’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.75M | Buy |
20,847
+10,654
| +105% | +$3.01M | 0.54% | 60 |
|
|
2026
Q1 | $2.72M | Buy |
10,193
+3,095
| +44% | +$856K | 0.45% | 68 |
|
|
2025
Q4 | $1.95M | Buy |
7,098
+1,923
| +37% | +$539K | 0.39% | 81 |
|
|
2025
Q3 | $1.49M | Buy |
5,175
+4,193
| +427% | +$1.24M | 0.33% | 101 |
|
|
2025
Q2 | $324K | Sell |
982
-23
| -2% | -$7.41K | 0.08% | 203 |
|
|
2025
Q1 | $330K | Sell |
1,005
-126
| -11% | -$38K | 0.09% | 206 |
|
|
2024
Q4 | $312K | Buy |
1,131
+1
| +0.1% | +$319 | 0.07% | 210 |
|
|
2024
Q3 | $392K | Sell |
1,130
-12
| -1% | -$4.13K | 0.11% | 188 |
|
|
2024
Q2 | $378K | Sell |
1,142
-1,356
| -54% | -$468K | 0.11% | 192 |
|
|
2024
Q1 | $907K | Buy |
2,498
+673
| +37% | +$222K | 0.35% | 90 |
|
|
2023
Q4 | $547K | Sell |
1,825
-54
| -3% | -$15.8K | 0.29% | 92 |
|
|
2023
Q3 | $538K | Sell |
1,879
-24
| -1% | -$6.84K | 0.32% | 87 |
|
|
2023
Q2 | $534K | Buy |
1,903
+9
| +0.5% | +$2.34K | 0.31% | 88 |
|
|
2023
Q1 | $484K | Sell |
1,894
-278
| -13% | -$81K | 0.28% | 95 |
|
|
2022
Q4 | $720K | Sell |
2,172
-94
| -4% | -$29.7K | 0.43% | 74 |
|
|
2022
Q3 | $629K | Buy |
2,266
+21
| +0.9% | +$5.91K | 0.41% | 81 |
|
|
2022
Q2 | $592K | Buy |
2,245
+685
| +44% | +$177K | 0.36% | 87 |
|
|
2022
Q1 | $374K | Buy |
1,560
+46
| +3% | +$10.8K | 0.19% | 115 |
|
|
2021
Q4 | $348K | Sell |
1,514
-33
| -2% | -$7.01K | 0.18% | 128 |
|
|
2021
Q3 | $310K | Sell |
1,547
-820
| -35% | -$178K | 0.17% | 141 |
|
|
2021
Q2 | $561K | Buy |
2,367
+878
| +59% | +$219K | 0.24% | 101 |
|
|
2021
Q1 | $360K | Sell |
1,489
-23
| -2% | -$5.13K | 0.16% | 131 |
|
|
2020
Q4 | $315K | Buy |
1,512
+22
| +1% | +$4.32K | 0.16% | 136 |
|
|
2020
Q3 | $252K | Buy |
1,490
+328
| +28% | +$57.7K | 0.09% | 219 |
|
|
2020
Q2 | $218K | Buy |
+1,162
| New | +$220K | 0.07% | 206 |
|
|
2020
Q1 | – | Sell |
-1,158
| Closed | -$237K | – | 223 |
|
|
2019
Q4 | $237K | Buy |
+1,158
| New | +$212K | 0.07% | 208 |
|
|
2019
Q1 | – | Sell |
-1,287
| Closed | -$244K | – | 316 |
|
|
2018
Q4 | $244K | Buy |
+1,287
| New | +$268K | 0.06% | 281 |
|
|
2018
Q2 | – | Sell |
-561
| Closed | -$94K | – | 422 |
|
|
2018
Q1 | $94K | Buy |
+561
| New | +$109K | 0.01% | 356 |
|
Other funds holding CI
Convergence Investment Partners's CI Position: Q2 2026 in Review
Convergence Investment Partners increased its Cigna (CI) stake by 105% in Q2 2026, buying an estimated $3.01M and bringing the position to 20,847 shares worth $5.75M. The position accounts for 0.54% of the portfolio, ranked #60.
Convergence Investment Partners first reported a position in CI in Q1 2018 and has held it in 28 quarters since. 1,702 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Convergence Investment Partners held 20,847 shares of Cigna worth $5.75M as of Q2 2026.
- Convergence Investment Partners bought 10,654 Cigna shares in Q2 2026, an estimated $3.01M.
- Cigna made up 0.54% of Convergence Investment Partners's portfolio in Q2 2026, its #60 holding.
- Convergence Investment Partners first reported a position in Cigna in Q1 2018 and has held it in 28 quarters since.
- 1,702 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on Convergence Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.